PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
27311540-1	2016	Agomelatine is a novel antidepressant with agonistic actions at melatonergic (MT1 and MT2 receptors) and antagonistic actions at 5HT-2C receptors.	agomelatine	0-11	5-hydroxytryptamine (serotonin) receptor 2C	Mus musculus	129-135	
25394903-14	2015	According to our findings, we concluded that agomelatine improves memory deficit and thus improves the effect of agomelatine arises from its 5HT-2C receptor antagonist activity.	agomelatine	45-56	5-hydroxytryptamine (serotonin) receptor 2C	Mus musculus	141-156	
25394903-14	2015	According to our findings, we concluded that agomelatine improves memory deficit and thus improves the effect of agomelatine arises from its 5HT-2C receptor antagonist activity.	agomelatine	113-124	5-hydroxytryptamine (serotonin) receptor 2C	Mus musculus	141-156	
33156577-7	2021	The antidepressant agomelatine had a similar effect than melatonin when applied alone but blocked the melatonin-promoted Gq activation due to its 5-HT2C antagonistic component.	agomelatine	19-30	5-hydroxytryptamine (serotonin) receptor 2C	Mus musculus	146-152	
23768699-7	2013	), a serotonin 5HT2C agonist, partially attenuated the anticompulsive effect of agomelatine (30 mg/kg).	agomelatine	80-91	5-hydroxytryptamine (serotonin) receptor 2C	Mus musculus	15-20	
23768699-12	2013	The results indicate that agomelatine has a potent anticompulsive effect that can be attributed to 5HT2C antagonism and MT1/2 agonism, and is certainly not mediated via its effects on the GABAergic system.	agomelatine	26-37	5-hydroxytryptamine (serotonin) receptor 2C	Mus musculus	99-104